Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
Core EBITDA Growth

    Back to All Ratios
VAISHALI PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

VAISHALI PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 2.11-68.1133.8294.6045.00

What is the latest Core EBITDA Growth ratio of VAISHALI PHARMA ?

The latest Core EBITDA Growth ratio of VAISHALI PHARMA is 2.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.11
Mar2024-68.11
Mar202333.82
Mar202294.60
Mar202145.00

How is Core EBITDA Growth of VAISHALI PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 2.11
Positive
Mar2024 -68.11
Negative
Mar2023 33.82
-64.25
Mar2022 94.6
110.22
Mar2021 45 -

Other Financial Ratios of VAISHALI PHARMA


Compare Core EBITDA Growth ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹99.3 Cr -5.2% 46.9% -42.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-5.2%

46.9%

-42.1%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses